Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab‐Paclitaxel in #PancreaticCancer: A Systematic Review 🧪 onlinelibrary.wiley.com/doi/10.1002/...

Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab‐Paclitaxel in Pancreatic Cancer: A Systematic Review

Background Pancreatic cancer (PC) is a lethal malignancy with a 5-year survival rate of 13% as the 7th leading cause of cancer-related death worldwide. Most patients are ineligible for resection at ...

onlinelibrary.wiley.com

In the United States, 40% of cancers are attributed to potentially preventable causes. February is #NationalCancerPreventionMonth, learn about cancer reduction in the AACR Cancer Progress Report: cancerprogressreport.aacr.org/progress/cpr...

Cervical cancer mortality in US women younger than 25 years significantly declined between 2016 and 2021, likely due to the widespread adoption of HPV vaccination. ja.ma/4i9ghPC